Patent · US Active

2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors

US7807673B2 · kind B2 · utility

4Cited by
6References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2006
Grant dateOct 5, 2010
Priority date
Expiry dateSep 28, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides 2-pyrimidinyl pyrazolopyridine compounds, compositions containing the same, as well as processes for the preparation and their use as pharmaceutical agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.